Background: Adaptive radiation therapy (ART) "flags," such as change in external
Adaptive radiation therapy (ART) protocols replan treatment in response to anatomical changes to ensure that planned target coverage and OAR sparing are achieved. While successful ART approaches may improve clinical outcomes, [1] [2] [3] they are resource intensive. 4, 5 Therefore, the clinical viability of ART depends on correctly identifying patients most likely to benefit from a replanned treatment. Selection criteria in the literature generally fall into three categories.
Image-based methods compare periodic cone beam CT (CBCT) or CT images with the CT simulation (CTsim) to identify any systematic physical changes. [6] [7] [8] [9] [10] Temporally based methods preselect the time at which a new plan should be calculated. 2, 11 Patient characteristicbased methods examine pretreatment parameters such as weight and tumor stage to predict if and when a replan may be necessary. 8, 12 In most protocols, these parameters indicate when a physician should make a judgment call regarding possible adjustment to immobilization, re-CT, dose recalculation, or replanning. Few dosimetric thresholds warranting a replan have been stated and efficient and easily implementable replan flags remain elusive. 2, 3, 8, 13, 14 Despite the variety of ART protocols used clinically, the accuracy of simple standard of practice ART replan candidate identification is rarely quantified in the literature. This work proposes a two-step, quantitative evaluation framework and exhibits its utility through the assessment of a single institution's clinical ART flag: a change in body contour exceeding 1.5 cm. Anecdotally, this type of flag is commonly used in many institutions. First, "ground truth" for dosimetric deviations requiring replanning were established by surveying radiation oncologists (ROs) treating HNCs. Second, flag performance was quantitatively assessed by comparing this "truth" to interfractional dose deviations. In this study, we assessed 15 HNC patients treated with VMAT whose body contour changed by >1.5 cm at some point in this treatment. This method of quantifying ART performance may allow clinics to identify more effective flags to improve clinical resource allocation and ultimately patient outcomes.
| METHODS

2.A | Protocol
For HNC VMAT patients treated in this study, kV-CBCT images
were acquired approximately every five fractions. For select cases, CBCTs were also acquired for the first three fractions to assess setup reproducibility; CBCT acquisition was delayed until a later fraction if the patient was feeling unwell, due to the prolonged on-unit time, and CBCT images may have been taken on the day after a flag in body contour change for additional monitoring. Patients were imaged on the treatment couch using CBCT after kV-orthogonal x-ray acquisition and subsequent couch position adjustment and prior to treatment delivery. Radiation therapists performed a rigid registration of each CBCT with the CTsim according to institutional image-guided radiation therapy practices. The axial view of the rigid registration was then assessed to identify, for any axial slice, the largest pointwise distance between the CBCT and CTsim external contours.
The latter was used to quantify change in body contour and formally may be regarded as a maximum axial slice-based Hausdorff distance. In practice, this flagged weight loss and tumor shrinkage effects as well as changes in shoulder position. Those patients exhibiting a change in body contour exceeding 1.5 cm were "flagged" for consult with a medical physicist. The RO in collaboration with the physicist would then elect to refit the immobilization, re-CT, and/or replan treatment; clinicians may have elected to monitor patients if only a few (e.g., less than 5) fractions remained.
2.B | Patients
Fifteen consecutively flagged patients exhibiting a greater than 
2.D | Protocol assessment
A survey was circulated to HNC ROs at our center and others in T A B L E 1 Characteristics of the patient cohort: 15 patients exhibiting a change in external body contour >1.5 cm. 
Patient
3.A | Survey results
Survey results are shown in As expected, enlargement effects were more detrimental to tumor coverage than was subsequent shrinkage. Table 2 ). Bold entries indicate fractions flagged by the protocol. (Contours: redhigh-dose GTV, orange -high-dose PTV, yellow -low-dose PTV, cyan -spinal cord, blue -spinal cord with margin, white -bolus). *Clinically significant deviation, according to the major/minor violation criteria (only those parameters violating Table 2 criteria are shown). † Lowdose PTV volume excludes the high-dose PTV volume. respect to the violation criteria, and demonstrated more favorable protocol performance when compared with the former case.
3.B | Protocol assessment
Truth table results are presented in Table 3 . Each fraction with CBCT acquisition is considered independently, giving 106 data points for the 15 patient cohort. For example, a fraction was classified as a true positive for target coverage (GTV, CTV, PTV) if the fraction was flagged by the institutional protocol and an unacceptable violation occurred in at least one of the GTV, high-dose CTV, low-dose CTV, high-dose PTV, or low-dose PTV dose parameters considered in Table 2 . We assessed overall and target (GTV, CTV) performance with and without including PTV parameters: CTV to PTV margins preserve CTV coverage under setup uncertainties so that modest compromises in PTV coverage are expected. However, degradation of PTV D95% and D99% may indicate that high doses are consequently deposited in surrounding healthy tissue and motivated its Table 2 ). Bold entries indicate fractions flagged by the protocol. (Contours: redhigh-dose GTV, orange -high-dose PTV, yellow -low-dose PTV, cyan -spinal cord, blue -spinal cord with margin). *Clinically significant deviation according to the major/minor violation criteria (only those parameters violating Table 2 criteria are shown). † Low-dose PTV volume excludes the high-dose PTV volume. 
| DISCUSSION
The practice of flagging patients exhibiting a change in external body contour exceeding 1.5 cm for possible reimmobilization, re-CT, and/ or replan was motivated by three-dimensional (3D)-conformal radiation therapy (3D-CRT) and IMRT dosimetric calculation techniques. Table 3 ).
major and minor violations would require the replanning of 13/15 of these "high-risk" patients. However, the extent to which dose discrepancies can be improved through replanning depends on factors such as patient anatomy and number of fractions remaining. While inferring the timing and frequency of replans required to avoid violations falls outside the scope of our retrospective study, the literature suggests that 2-3 replans in the first half of treatment is the most effective. 11, 16, 17 This study is limited by the necessary use of major/minor viola- The literature suggests alternate metrics which may also be assessed via a similar truth-table approach. Interfractional variation in face and neck diameter has been correlated with an increase in xerostomia scores 10 and deviations in target coverage and hot spot location. 6 Superior shifts in shoulder position have been shown to decrease low-dose PTV coverage, with inferior shifts increasing dose to the brachial plexus. 20 Despite the limited use of weight loss-based metrics, 13, 16 changes in patient weight correlate with an increase in spinal cord Dmax 6,9 and a medial shift of parotid centers of mass toward high-dose regions. 7,11 A 1 cm change in body contour metric has been used by Brown et al. 12 as a preliminary step in prospective ART cohort acquisition. The efficacy of the latter metric compared to RO decision-making is not explicit in the study, which examines subsequent model development on the high-risk cohort. In contrast, logistic regression and nomography have been used to assess the predictive capability of complex, multiparameter ART protocols which use data acquired prior to and during treatment. 12, 15 Our proposed framework may be used to assess the predictive capabilities of simple standard of care or multimetric flags characterized by a normal/abnormal threshold.
| CONCLUSION
A framework to quantify ART protocol performance in comparison to RO-specified unacceptable dose violation criteria was demonstrated for a common ART flagging metric: >1.5 cm change in external body contour. This framework successfully identified a mismatch between the flag's intended purpose of identifying changes in central-axis dose and the physician priorities to correct for geometric shifts. This work suggests that centers may similarly benefit by quantifying ART performance according to center-specific requirements.
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APPEN DIX A
(The following uses the notation TP = true positive, FP = false positive, TN = true negative, FN = false negative in keeping with Table 3 and Fig. 3 .)
To elaborate on how the 27% sensitivity of a random flag on a comparable patient sample is derived, we first assumed that approximately 26/121 fractions are flagged (TP + FP = 20%) while only 15% of fractions exhibit a clinically significant effect (TP + FN = 15%).
These proportions are in keeping with that of the study cohort. In addition, TP + FN + FP + TN = 100%. Furthermore, from analysis of receiver operating characteristic curves, we assume that a random flag is such that sensitivity is approximately equal to (1 − specificity): i.e., sensitivity = 4%/(4% + 11%) = 27%.
